tirzepatide from eli lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Eli Lilly Says Its Obesity

CEO Tamar Grossman says the recognition reflects how far the company has come despite limited resources

Bioidentical hormone therapy utilizes hormones identical to those your body naturally produces, while traditional hormone replacement therapy might involve synthetic or animal-derived hormones

In Dallas overall, weve seen a 35% drop in alcohol sales across the board, and I think a lot of that has to do with GLP-1s, he said

That means roughly 25% of employers are receiving something less than a guaranteed full pass-through on traditional drugs and the arrangement for that 25% is often governed by contracts that do not disclose the actual rebate amount received from manufacturers

Whether hyperglycaemia itself directly affects the pathogenesis of atherosclerosis and heart failure remains inconclusive